Literature DB >> 22813746

FoxM1 regulates mammary luminal cell fate.

Janai R Carr1, Megan M Kiefer, Hyun Jung Park, Jing Li, Zebin Wang, Joel Fontanarosa, Danielle DeWaal, Dragana Kopanja, Elizaveta V Benevolenskaya, Grace Guzman, Pradip Raychaudhuri.   

Abstract

Elevated expression of FoxM1 in breast cancer correlates with an undifferentiated tumor phenotype and a negative clinical outcome. However, a role for FoxM1 in regulating mammary differentiation was not known. Here, we identify another function of FoxM1, the ability to act as a transcriptional repressor, which plays an important role in regulating the differentiation of luminal epithelial progenitors. Regeneration of mammary glands with elevated levels of FoxM1 leads to aberrant ductal morphology and expansion of the luminal progenitor pool. Conversely, knockdown of FoxM1 results in a shift toward the differentiated state. FoxM1 mediates these effects by repressing the key regulator of luminal differentiation, GATA-3. Through association with DNMT3b, FoxM1 promotes methylation of the GATA-3 promoter in an Rb-dependent manner. This study identifies FoxM1 as a critical regulator of mammary differentiation with significant implications for the development of aggressive breast cancers.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22813746      PMCID: PMC3401379          DOI: 10.1016/j.celrep.2012.05.005

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  50 in total

1.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

2.  CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.

Authors:  P S Yan; M R Perry; D E Laux; A L Asare; C W Caldwell; T H Huang
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation.

Authors:  Lluis Fajas; Viviane Egler; Raphael Reiter; Jacob Hansen; Karsten Kristiansen; Marie-Bernard Debril; Stéphanie Miard; Johan Auwerx
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 5.  Stromal effects on mammary gland development and breast cancer.

Authors:  Bryony S Wiseman; Zena Werb
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

6.  FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors.

Authors:  Zebin Wang; Hyun Jung Park; Janai R Carr; Yi-ju Chen; Yu Zheng; Jing Li; Angela L Tyner; Robert H Costa; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2011-04-20       Impact factor: 12.701

Review 7.  The RB and p53 pathways in cancer.

Authors:  Charles J Sherr; Frank McCormick
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

8.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

9.  E2Fs regulate adipocyte differentiation.

Authors:  Lluis Fajas; Rebecca L Landsberg; Yolande Huss-Garcia; Claude Sardet; Jacqueline A Lees; Johan Auwerx
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

10.  Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators.

Authors:  Michael L Major; Rita Lepe; Robert H Costa
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more
  41 in total

1.  Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.

Authors:  Vaibhav Chand; Akshay Pandey; Dragana Kopanja; Grace Guzman; Pradip Raychaudhuri
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

2.  A Gene Regulatory Program in Human Breast Cancer.

Authors:  Renhua Li; John Campos; Joji Iida
Journal:  Genetics       Date:  2015-10-28       Impact factor: 4.562

3.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.

Authors:  Jianfei Xue; Xia Lin; Wen-Tai Chiu; Yao-Hui Chen; Guanzhen Yu; Mingguang Liu; Xin-Hua Feng; Raymond Sawaya; René H Medema; Mien-Chie Hung; Suyun Huang
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.

Authors:  Bhopal Mohapatra; Neha Zutshi; Wei An; Benjamin Goetz; Priyanka Arya; Timothy A Bielecki; Insha Mushtaq; Matthew D Storck; Jane L Meza; Vimla Band; Hamid Band
Journal:  Development       Date:  2017-01-18       Impact factor: 6.868

Review 5.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

6.  Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression.

Authors:  Jianfei Xue; Aidong Zhou; Christina Tan; Yamei Wu; Hsueh-Te Lee; Wenliang Li; Keping Xie; Suyun Huang
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

7.  Expression of polycomb targets predicts breast cancer prognosis.

Authors:  Alba Jene-Sanz; Renáta Váraljai; Alexandra V Vilkova; Galina F Khramtsova; Andrey I Khramtsov; Olufunmilayo I Olopade; Nuria Lopez-Bigas; Elizaveta V Benevolenskaya
Journal:  Mol Cell Biol       Date:  2013-08-05       Impact factor: 4.272

8.  Sumoylation pathway is required to maintain the basal breast cancer subtype.

Authors:  Maria V Bogachek; Yizhen Chen; Mikhail V Kulak; George W Woodfield; Anthony R Cyr; Jung M Park; Philip M Spanheimer; Yingyue Li; Tiandao Li; Ronald J Weigel
Journal:  Cancer Cell       Date:  2014-05-15       Impact factor: 31.743

9.  Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.

Authors:  Li Li; Kiran Kumar Naidu Guturi; Brandon Gautreau; Parasvi S Patel; Amine Saad; Mayako Morii; Francesca Mateo; Luis Palomero; Haithem Barbour; Antonio Gomez; Deborah Ng; Max Kotlyar; Chiara Pastrello; Hartland W Jackson; Rama Khokha; Igor Jurisica; El Bachir Affar; Brian Raught; Otto Sanchez; Moulay Alaoui-Jamali; Miguel A Pujana; Anne Hakem; Razq Hakem
Journal:  J Clin Invest       Date:  2018-08-02       Impact factor: 14.808

10.  FOXM1 coming of age: time for translation into clinical benefits?

Authors:  Muy-Teck Teh
Journal:  Front Oncol       Date:  2012-10-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.